These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1826446)

  • 1. Induction of natural killer activity by xanthenone analogues of flavone acetic acid: relation with antitumour activity.
    Ching LM; Joseph WR; Zhuang L; Atwell GJ; Rewcastle GW; Denny WA; Baguley BC
    Eur J Cancer; 1991; 27(1):79-83. PubMed ID: 1826446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents.
    Zwi LJ; Baguley BC; Gavin JB; Wilson WR
    Oncol Res; 1994; 6(2):79-85. PubMed ID: 7949468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid.
    Ching LM; Finlay GJ; Joseph WR; Baguley BC
    Eur J Cancer; 1991; 27(12):1684-9. PubMed ID: 1782083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.
    Futami H; Eader L; Back TT; Gruys E; Young HA; Wiltrout RH; Baguley BC
    J Immunother (1991); 1992 Nov; 12(4):247-55. PubMed ID: 1477076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues.
    Thomsen LL; Ching LM; Joseph WR; Baguley BC; Gavin JB
    Biochem Pharmacol; 1992 Jun; 43(11):2401-6. PubMed ID: 1610403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory actions of xanthenone anticancer agents.
    Baguley BC; Ching LM
    BioDrugs; 1997 Aug; 8(2):119-27. PubMed ID: 18020500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
    Thomsen LL; Ching LM; Baguley BC
    Cancer Res; 1990 Nov; 50(21):6966-70. PubMed ID: 2170013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.
    Veszelovszky E; Thomsen LL; Li Z; Baguley BC
    Eur J Cancer; 1993; 29A(3):404-8. PubMed ID: 8398341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells.
    Damia G; Tagliabue G; Allavena P; D'Incalci M
    Cancer Immunol Immunother; 1990; 32(4):241-4. PubMed ID: 2261598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flavone acetic acid (NSC 347,512) on splenic cytotoxic effector cells and their role in tumour necrosis.
    Ching LM; Baguley BC
    Eur J Cancer Clin Oncol; 1989 May; 25(5):821-8. PubMed ID: 2737219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.
    McKeage MJ; Kestell P; Denny WA; Baguley BC
    Cancer Chemother Pharmacol; 1991; 28(6):409-13. PubMed ID: 1934244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
    Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
    Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid.
    Ching LM; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1061-5. PubMed ID: 2597283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Baguley BC; Cole G; Thomsen LL; Li Z
    Cancer Chemother Pharmacol; 1993; 33(1):77-81. PubMed ID: 8269593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for substituted 9-oxo-9,10-dihydroacridine-4-acetic acids: analogues of the colon tumour active agent xanthenone-4-acetic acid.
    Gamage SA; Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
    Anticancer Drug Des; 1992 Oct; 7(5):403-14. PubMed ID: 1388631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer.
    Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH
    Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of the novel antitumour agent xanthenone-4-acetic acid in the mouse: identification of metabolites and routes of elimination.
    Kestell P; Rewcastle GW; Baguley BC
    Xenobiotica; 1994 Jul; 24(7):635-47. PubMed ID: 7975728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.
    Ching LM; McKeage MJ; Joseph WR; Kestell P; Zwi LJ; Baguley BC
    Cancer Chemother Pharmacol; 1991; 28(6):414-9. PubMed ID: 1934245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of superoxide production from murine macrophages by the antitumour agent flavone acetic acid and xanthenone acetic acid analogues.
    Thomsen LL; Baguley BC; Ching LM; Gavin JB
    Biochem Pharmacol; 1992 Jan; 43(2):386-9. PubMed ID: 1310856
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.
    Woon ST; Reddy CB; Drummond CJ; Schooltink MA; Baguley BC; Kieda C; Ching LM
    Oncol Res; 2005; 15(7-8):351-64. PubMed ID: 16491953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.